The deficit in mAChR-dependent LTD was at least partially reversed by bath application of the acetylcholinesterase donepezil (marketed under the trade name Aricept and licensed for the treatment of mild-to-moderate Alzheimer’s disease), suggesting that the LTD deficit was related to dysfunction in the cholinergic system. Here, ACHE is linked to Alzheimer disease.